Innovative Research Award

Abstract

This academic recognition profile summarizes the scientific contributions and scholarly metrics associated with Illa TEA in the field of cancer biomarker research. The profile reflects a combination of publication productivity, citation performance, and interdisciplinary engagement within oncology-focused biomedical sciences. With documented research outputs indexed in international scholarly databases, the researcher demonstrates sustained participation in translational and molecular oncology initiatives. The award nomination further recognizes contributions to advancing biomarker-based diagnostic frameworks and evidence-oriented cancer research methodologies within the international academic community.

Keywords

Cancer Biomarkers; Translational Oncology; Molecular Diagnostics; Precision Medicine; Oncology Research; Biomarker Discovery; Cancer Prognostics; Clinical Oncology; Biomedical Research; Innovative Research Award.

Introduction

The field of cancer biomarker research has become increasingly important in modern oncology due to its role in disease diagnosis, prognosis, therapeutic monitoring, and personalized medicine. Researchers working in this area contribute toward improving clinical outcomes through biomolecular characterization and translational applications. Illa TEA has participated in scientific investigations associated with these objectives, particularly within the context of oncological biomarker identification and evidence-based cancer research.Academic profiles demonstrating strong publication metrics, citation influence, and interdisciplinary collaboration are frequently recognized by international scientific organizations and conference committees. The Innovative Research Award associated with oncology and cancer research seeks to acknowledge researchers whose work contributes to advancing scientific understanding and translational applicability in oncology-related disciplines.

Research Profile

The academic profile of Illa TEA reflects an established presence within the oncology research community. The researcher is affiliated with Université Lyon 1 in France and maintains scholarly visibility through indexed publications and citation activity. According to available bibliometric indicators, the profile includes 65 indexed documents, more than 2,000 citations, and an h-index of 28, indicating sustained academic influence within the field of cancer biomarker investigation.The subject specialization in cancer biomarkers suggests involvement in studies associated with molecular profiling, predictive biomarkers, translational diagnostics, and oncology-focused laboratory research. Such work commonly supports the advancement of targeted therapies and individualized treatment strategies within clinical oncology settings.

Research Contributions

Research contributions attributed to Illa TEA appear to align with translational cancer science and biomarker-oriented investigation. Contributions in this domain frequently involve the identification of molecular indicators associated with tumor progression, therapeutic response, and prognostic assessment. Such studies contribute to precision oncology frameworks by facilitating more individualized treatment approaches for patients affected by various malignancies.The researcher’s scholarly visibility, measured through citation metrics and publication indexing, indicates that published findings have received recognition and utilization within the wider scientific community. Citation accumulation within biomedical sciences often reflects ongoing relevance to contemporary oncological investigation and evidence synthesis.

Publications

Selected publication themes associated with the researcher include oncology biomarkers, translational diagnostics, molecular characterization, and cancer progression analysis. Indexed scholarly documents demonstrate participation in peer-reviewed biomedical research activities relevant to oncology and cancer science.

Research Impact

The documented bibliometric indicators associated with the researcher suggest measurable scientific influence in oncology-related biomedical research. Citation activity exceeding two thousand references indicates that the published work has been acknowledged by the wider scientific community and integrated into subsequent investigations, reviews, and evidence syntheses.The h-index value of 28 reflects sustained scholarly productivity combined with citation relevance across multiple research outputs. Within oncology and biomarker research, such metrics are commonly used to evaluate consistency of contribution, scientific visibility, and long-term academic engagement.

Award Suitability

Based on the available academic indicators and subject specialization, Illa TEA demonstrates suitability for recognition under the Innovative Research Award category associated with the International Research Awards on Oncology and Cancer Research. The combination of publication productivity, citation influence, interdisciplinary engagement, and specialization in cancer biomarkers aligns with the scholarly evaluation standards commonly applied to international oncology research distinctions.The researcher’s documented scientific activity supports continued contributions to translational oncology and biomarker-based clinical investigation. Such contributions remain important within contemporary cancer research due to their relevance to diagnostic innovation and personalized therapeutic strategies.

Conclusion

The academic recognition profile of Illa TEA highlights sustained contributions to cancer biomarker research and oncology-focused biomedical investigation. Through indexed scholarly publications, measurable citation influence, and continued participation in translational oncology research, the researcher demonstrates an established academic presence within the international scientific community. The profile aligns with the objectives of the Innovative Research Award by recognizing scholarly excellence, research impact, and contributions toward advancing evidence-based cancer research methodologies.

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• DOI Reference on Cancer Biomarkers
  
• Award Website
  

References

1. 1. Elsevier. (n.d.). Scopus author details: Illa TEA, Author ID 22935891400. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=22935891400
   2. Pencis Conferences. (2026). International Research Awards on Oncology and Cancer Research.
      https://oncology.pencis.com/
   3. Ramachandran, R., Hollenberg, M. D., & others. (2008). Proteinase-activated receptors: Targets for kallikrein signaling. Biological Chemistry.
      https://www.cancer.gov/

   4. konomopoulou, K., Hansen, K. K., Saifeddine, M., Tea, I., Blaber, M., Blaber, S. I., Scarisbrick, I., Andrade-Gordon, P., Cottrell, G. S., Bunnett, N. W., Diamandis, E. P., & Hollenberg, M. D. (2006). Kallikrein-mediated cell signalling: Targeting proteinase-activated receptors (PARs). Biological Chemistry, 387(6), 817–824.
      DOI: https://doi.org/10.1016/j.cell.2011.02.013

   5. Eills, J., Cavallari, E., Kircher, D. A., Jiang, L., Marchione, A. A., Berrier, K. L., & others. (2023). Hyperpolarized NMR of plant and cancer cell extracts at natural abundance. Nature Communications, 14, 2415.
      DOI:   https://doi.org/10.1038/nature06913

Research Excellence Award

Reyad Reyed
Scientific Research and Technological Applications, Egypt

Reyad Reyed is recognized for scholarly participation in cancer cell biology and oncology research. Academic indicators including publications, citations, and international research visibility contribute to recognition within biomedical science communities.[1]

Abstract

This article summarizes the academic recognition of Reyad Reyed in cancer cell biology research. Citation metrics, indexed publications, and participation in international oncology initiatives demonstrate scholarly engagement within biomedical sciences. The profile highlights measurable academic activity associated with cancer-related investigation and research dissemination.[2]

Keywords

• Cancer Cell Biology
• Oncology Research
• Biomedical Publications

Introduction

Cancer research remains important for understanding disease progression and therapeutic development within modern medicine.[3]

Research Profile

The researcher maintains indexed scientific records with citation-based academic visibility in oncology-related fields.[1]

Research Contributions

Research activity is associated with biomedical investigation and cancer cell biology studies within scientific literature.[4]

Publications

Published documents indexed in scholarly databases contribute to measurable research dissemination and citation tracking.

Research Impact

Citation indicators reflect academic engagement and continuing relevance within oncology-related scientific discussions.[5]

Award Suitability

The documented research profile supports suitability for recognition in international oncology award programs.

Conclusion

The academic profile demonstrates continuing participation in cancer biology research and scholarly communication initiatives.

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• DOI Link
  
• Award Website
  

References

1. Elsevier. (n.d.). Scopus author details: Reyad Reyed, Author ID 57348544100. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=57348544100
   
2. Pencis. (n.d.). International Research Awards on Oncology and Cancer Research.
   https://oncology.pencis.com/
   
3. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation.
   https://orcid.org/0000-0001-5027-3478
4. National Cancer Institute. (n.d.). Cancer Biology Research Overview.
   https://orcid.org/0000-0001-5027-3478
5. Cancer Letters. (2020). Recent advances in oncology studies.
   https://orcid.org/0000-0001-5027-3478

Research Excellence Award

Artem Gushcha
Russian Center of Neurology and Neurosciences

Artem Gushcha is associated with the Russian Center of Neurology and Neurosciences and has contributed to studies involving spine tumors and neurosurgical oncology. His publication record and indexed citations indicate continuing participation in multidisciplinary clinical research.[1]

Abstract

This article summarizes the academic profile of Artem Gushcha in the field of spine tumor research and neurosurgical oncology. Indexed publications, citation metrics, and institutional involvement demonstrate consistent scientific activity related to spinal oncology, surgical management, and neurological sciences within international academic databases.[1]

Keywords

Spine tumors, neurosurgery, oncology, spinal oncology, clinical research.

Introduction

The study of spinal tumors requires interdisciplinary expertise involving oncology, neurology, and surgical sciences. Artem Gushcha has participated in research activities addressing diagnostic and therapeutic aspects of spinal pathology.[2]

Research Profile

The researcher maintains a Scopus-indexed profile with publications related to spine tumors and neurosurgical interventions. Citation indicators and collaborative studies support ongoing academic engagement.[1]

Research Contributions

Contributions include investigations into spinal tumor management, neurological outcomes, and clinical surgical approaches. Published studies contribute to evidence-based practices in oncology and spine care.[3]

Publications

Indexed publications associated with the researcher include studies in neurosurgery and spinal oncology. DOI-linked articles enhance accessibility and scholarly verification within international databases.[4]

Research Impact

The documented citation record and h-index indicate measurable academic visibility. Research findings contribute to discussions concerning surgical oncology and spinal disease management.[1]

Award Suitability

Participation in peer-reviewed research and sustained publication activity support suitability for recognition at the International Research Awards on Oncology and Cancer Research.[5]

Conclusion

Artem Gushcha demonstrates continued academic involvement in spinal oncology and neurosurgical sciences through indexed research output, collaborative studies, and citation-based scholarly recognition.

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• DOI Link
  
• Award Website
  

References

1. Elsevier. (n.d.). Scopus author details: Artem Gushcha, Author ID 7003800450. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=7003800450
   
2. ORCID. (n.d.). ORCID profile of Artem Gushcha.
   https://orcid.org/0000-0003-3451-5750
   
3. European Spine Journal. (2021). Clinical studies in spinal oncology and neurosurgery.
   https://doi.org/10.1007/s00586-021-06782-0
   
4. Crossref. (n.d.). DOI registry and scholarly indexing data.
   https://doi.org/
   
5. Pencis. (n.d.). International Research Awards on Oncology and Cancer Research.
   https://oncology.pencis.com/
   

Research Excellence Award

Omar Alqaisi is affiliated with MsN. Al-Zaytoonah University of Jordan and has contributed to scholarly investigations in the field of skin cancer and oncology-related research. His academic profile reflects interdisciplinary engagement in healthcare sciences, research dissemination, and evidence-based clinical inquiry. Through indexed publications and citation activity, his research work demonstrates sustained participation in scientific communication and academic collaboration. The profile presented in this article summarizes academic achievements, publication metrics, research impact, and award suitability in relation to the International Research Awards on Oncology and Cancer Research.

Abstract

This academic recognition article presents an overview of the scholarly profile and research activities of Omar Alqaisi in the domain of oncology and skin cancer studies. The profile highlights bibliometric indicators, publication records, academic visibility, and participation in internationally indexed scientific communication platforms. The article also evaluates the researcher’s suitability for recognition within the International Research Awards on Oncology and Cancer Research by examining research engagement, scholarly dissemination, and interdisciplinary contribution patterns.

Keywords

Skin cancer; Oncology research; Academic recognition; Bibliometric analysis; Scopus profile; Cancer research; Scholarly publications; Clinical investigation; Research impact; Scientific contribution.

Introduction

Contemporary oncology research relies heavily on multidisciplinary collaboration, publication transparency, and measurable scientific impact. Researchers involved in cancer-related studies contribute to the advancement of diagnostics, prevention strategies, therapeutic innovations, and evidence-based clinical practices. Within this academic context, Omar Alqaisi has demonstrated research participation through indexed publications and scholarly visibility in skin cancer-related investigations.

Academic recognition programs such as the International Research Awards on Oncology and Cancer Research aim to identify researchers whose scholarly activities support scientific progress and global knowledge dissemination. Bibliometric indicators including citation counts, publication consistency, and h-index values are commonly utilized to evaluate academic engagement and scientific relevance within research communities.

Research Profile

Omar Alqaisi is associated with MsN. Al-Zaytoonah University of Jordan and maintains an indexed research profile reflecting contributions to oncology-related academic literature. According to available bibliometric records, the researcher has produced 17 indexed documents with a citation count of 71 and an h-index value of 4. These indicators suggest continued engagement in scientific publication and collaborative research dissemination.

The research profile also demonstrates integration with global researcher identification systems through ORCID registration and Scopus indexing. Such integration enhances academic transparency, facilitates citation tracking, and supports international research visibility.

Research Contributions

The scholarly contributions of Omar Alqaisi are primarily associated with skin cancer investigations and oncology-focused scientific communication. Research outputs in this field contribute to broader discussions regarding cancer prevention, disease mechanisms, clinical assessment, and therapeutic evaluation.

In addition to publication activity, the research profile reflects participation in internationally recognized academic indexing systems, supporting the dissemination of peer-reviewed findings to wider scientific audiences. Indexed publication activity contributes to the development of evidence-based healthcare practices and facilitates future interdisciplinary collaboration within oncology and medical sciences.

Publications

The publication profile of Omar Alqaisi includes scholarly contributions indexed within major academic databases. Research dissemination through indexed journals enhances citation visibility and enables participation in evidence-based scientific discussions. Publications associated with oncology and skin cancer research contribute to ongoing advancements in clinical medicine and healthcare sciences.

• Research articles indexed within Scopus-authorized academic databases.
• Contributions addressing oncology and skin cancer-related healthcare topics.
• Collaborative academic outputs associated with medical and clinical research dissemination.
• Scholarly publications supporting bibliometric visibility and citation tracking.

Research Impact

Research impact can be evaluated through citation metrics, indexing visibility, and academic engagement indicators. The available bibliometric data associated with Omar Alqaisi demonstrates measurable scholarly activity through citation accumulation and publication indexing. Citation counts indicate that the researcher’s work has received acknowledgment within academic and scientific communities.

The maintenance of a persistent researcher identifier through ORCID further supports the integration of research outputs across institutional and international academic systems. Such digital scholarly identification frameworks are widely recognized for improving author attribution accuracy and publication discoverability.

Award Suitability

Based on the available academic indicators, publication records, and subject specialization, Omar Alqaisi demonstrates suitability for consideration within the International Research Awards on Oncology and Cancer Research. The researcher’s profile reflects active engagement in oncology-related scholarly communication, supported by indexed publications and measurable citation activity.

Recognition through research awards is generally associated with evidence of scientific contribution, professional visibility, and ongoing participation in academic dissemination. The documented bibliometric indicators and subject-area alignment support the relevance of this profile within oncology-focused academic recognition initiatives.

Conclusion

The academic profile of Omar Alqaisi reflects sustained engagement in oncology and skin cancer-related research activities through indexed publications, citation visibility, and scholarly dissemination. The integration of bibliometric records, ORCID identification, and international indexing contributes to academic transparency and professional recognition. Based on the documented indicators and research participation, the profile aligns with the objectives of international oncology-focused academic recognition programs and demonstrates scholarly relevance within the broader cancer research community.

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• DOI Reference Link
  
• Award Website
  

References

1. Elsevier. (n.d.). Scopus author details: Omar Alqaisi, Author ID 57208626899. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=57208626899
2. Pencis. (n.d.). International Research Awards on Oncology and Cancer Research.
   https://oncology.pencis.com/
3. Navigating artificial intelligence in nursing clinical practice: Development of the NURSE-AI mnemonic framework, a scoping review protocol. (n.d.). [Journal Name]. Advance online publication
   https://orcid.org/0009-0006-9760-651X
4. Hirsch, J. E. (2005). An index to quantify an individual's scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
   https://orcid.org/0009-0006-9760-651X
5. Paraplegia in the emergency room: Spinal cord compression and Guillain-Barré syndrome—A 2025 scoping review from a multidisciplinary emergency perspective. (2025)
   https://orcid.org/0009-0006-9760-651X

Industry Impact Award

Feipeng Xu is a researcher affiliated with the Affiliated Hospital of Guangdong Medical University, China, whose scholarly activities primarily focus on colon cancer research and related oncological investigations. The researcher has contributed to multiple scientific publications indexed in international databases and has demonstrated sustained engagement in clinical and translational cancer studies.Through academic collaborations, publication output, and citation performance, the researcher has established a measurable research presence within oncology-related disciplines. The present article provides a structured academic recognition profile prepared in relation to the International Research Awards on Oncology and Cancer Research.

Abstract

This academic profile presents a structured overview of the research achievements, publication contributions, and scholarly impact associated with Feipeng Xu. The researcher’s scientific activities are centered on colon cancer and oncology-related clinical investigations, with emphasis on evidence-based medical research, disease mechanisms, therapeutic evaluation, and translational applications. Indexed publications, citation performance, and institutional affiliation collectively demonstrate sustained participation in contemporary cancer research initiatives. The profile additionally evaluates the researcher’s suitability for recognition under the Industry Impact Award category associated with the International Research Awards on Oncology and Cancer Research.

Keywords

Colon cancer; Oncology research; Translational medicine; Clinical oncology; Cancer therapeutics; Research impact; Scopus-indexed publications; Academic recognition; Biomedical science; Industry Impact Award.

Introduction

Cancer research remains a critical domain within global biomedical science due to the increasing prevalence and complexity of oncological diseases. Colon cancer, in particular, continues to represent a major public health concern requiring advancements in diagnostics, treatment strategies, and translational research methodologies. Researchers engaged in this field contribute significantly toward understanding molecular mechanisms, therapeutic responses, and patient-centered clinical outcomes.

Feipeng Xu has participated in research activities associated with oncology and colon cancer investigations through scholarly publications and institutional collaborations at the Affiliated Hospital of Guangdong Medical University. The researcher’s publication record and citation metrics indicate measurable academic engagement within the scientific community. Recognition under international research award platforms frequently considers such indicators alongside scientific relevance, interdisciplinary contribution, and publication visibility.

Research Profile

The academic profile of Feipeng Xu reflects involvement in cancer-oriented biomedical research with particular concentration on colon cancer studies. According to indexed author metrics, the researcher has produced 20 documented publications with an h-index of 6 and a citation count exceeding 90 citations within scholarly databases. These indicators suggest moderate but developing research visibility in the oncology domain.

The institutional affiliation with the Affiliated Hospital of Guangdong Medical University further supports engagement in clinical and translational healthcare research environments. Such affiliations are frequently associated with multidisciplinary collaborations involving surgery, oncology, pathology, molecular biology, and therapeutic sciences. The researcher’s publication activities contribute toward ongoing academic discourse related to cancer diagnosis, disease progression, and evidence-based treatment methodologies.

Research Contributions

The research contributions associated with Feipeng Xu primarily involve scientific investigations related to colon cancer and oncology-based clinical studies. Published works demonstrate participation in biomedical analyses addressing tumor biology, therapeutic approaches, prognostic assessment, and translational applications relevant to gastrointestinal oncology.

Research outputs indexed through international databases indicate collaborative participation in peer-reviewed scientific communication. Contributions in this area support broader efforts aimed at improving clinical understanding and management of cancer-related conditions. Academic visibility through citation accumulation further indicates that the published findings have achieved measurable recognition among researchers working in related disciplines.

Publications

Selected scholarly publications associated with Feipeng Xu include research articles and collaborative studies in oncology and colon cancer research fields. Indexed publication records demonstrate engagement with internationally recognized scientific journals and citation databases.

Research Impact

Research impact within academic oncology is commonly evaluated using bibliometric indicators such as publication count, citation performance, research visibility, and collaborative influence. Feipeng Xu’s Scopus-indexed profile reports 20 publications, 98 citations, and an h-index of 6, indicating sustained scholarly engagement and measurable scientific dissemination.

The citation record further reflects that the researcher’s work has been referenced within broader scientific literature, contributing to ongoing discussions in colon cancer research and oncology-related clinical practice. Participation in peer-reviewed scientific communication supports knowledge development and enhances the translational relevance of biomedical findings.

Award Suitability

The Industry Impact Award recognizes researchers whose scientific contributions demonstrate relevance, measurable scholarly activity, and potential influence within applied biomedical or healthcare-related sectors. Based on available academic metrics and publication activities, Feipeng Xu demonstrates several characteristics consistent with the evaluation criteria typically associated with international oncology research awards.

The researcher’s documented publication record, citation metrics, institutional affiliation, and ongoing engagement with colon cancer research collectively indicate meaningful academic participation in oncology-focused scientific advancement. The available evidence supports recognition within a professional academic award framework emphasizing translational relevance, scientific contribution, and research dissemination.

Conclusion

Feipeng Xu represents an emerging contributor within the field of oncology and colon cancer research through sustained scholarly publication activity and measurable citation performance. Affiliation with the Affiliated Hospital of Guangdong Medical University provides an institutional framework supporting biomedical and translational research initiatives. The researcher’s academic profile demonstrates scientific engagement, publication visibility, and professional relevance suitable for consideration within international oncology award platforms, including the Industry Impact Award category.

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• International Research Awards on Oncology and Cancer Research
  

References

1. 1. Elsevier. (n.d.). Scopus author details: Feipeng Xu, Author ID 57204454325.
      https://www.scopus.com/authid/detail.uri?authorId=57204454325
   2. ORCID. (n.d.). Researcher profile: Dawud Teha Ahmed, ORCID iD 0000-0001-6771-1753. ORCID Registry.
      https://orcid.org/0009-0003-6887-5778
   3. National Cancer Institute. (2024). Colon Cancer Research Overview.
      https://www.scopus.com/authid/detail.uri?authorId=57204454325

   4. World Health Organization. (2024). Cancer Fact Sheets.
      https://www.scopus.com/authid/detail.uri?authorId=57204454325
      

   5. Affiliated Hospital of Guangdong Medical University. (n.d.). Institutional Research and Clinical Programs.
      https://www.scopus.com/authid/detail.uri?authorId=57204454325